Novel antagonists of the glucagon receptor

Details for Australian Patent Application No. 2008212816 (hide)

Owner Metabasis Therapeutics, Inc.

Inventors Chen, Mingwei; Li, Haiqing; Reddy, Raja K.; Mali, Venkat Reddy; Lemus, Robert Huerta; Nguyen, Thanh Huu; Van Poelje, Paul D.; Gomez-Galeno, Jorge E.; Dang, Qun; Craigo, William; Boyer, Serge Henri; Hecker, Scott J.; Grote, Matthew P.; Sun, Zhili

Agent Spruson & Ferguson

Pub. Number AU-A-2008212816

PCT Pub. Number WO2008/098244

Priority 60/989,287 20.11.07 US; 60/889,183 09.02.07 US

Filing date 11 February 2008

Wipo publication date 14 August 2008

International Classifications

C07C 311/08 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 233/29 (2006.01) Carboxylic acid amides

C07C 235/56 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/098244 Priority application(s): WO2008/098244

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008212820-Particles for detecting intracellular targets

2008212808-Droplet actuator devices and methods employing magnetic beads